Skip to content

Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB

Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Catch in the Detection of Asymptomatic Bacteriuria in an Obstetric Population

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05554081
Acronym
Peezy-DAB
Enrollment
200
Registered
2022-09-26
Start date
2022-08-01
Completion date
2024-10-31
Last updated
2024-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asymptomatic Bacteriuria, Urinary Tract Infections

Brief summary

This study aims specifically to compare the rates of contaminants between standard clean-catch urine collection and urine collected using the PEEZY device. In particular, this study will compare the rates of contamination as stratified by BMI status (i.e., BMI \< 30 and BMI ≥30). Based on previous studies through LUHS and the Wolfe lab, we anticipate a reduction in contamination from sample collected using the PEEZY device, particularly among those pregnant women with BMI ≥30. To investigate this hypothesis we have designed a prospective unblinded randomized controlled trial comparing voided urine specimens obtained for asymptomatic bacteriuria in pregnant women presenting for obstetric care with use of standard clean-catch (CC) sampling method versus specimen obtained using PEEZY collection device.

Detailed description

Recruitment procedures 1. All patients scheduled for NOB (new obstetrics) appointments at LOC will be screened for eligibility by residents and fellows 2. Residents and fellows will recruit participants at LOC and obtain informed consent. 3. There will not be any advertising for this study and no recruitment materials will be given to eligible participants. Study procedures 4. Residents and fellows will use a REDCaps database to assign randomization, generate de-identified study labels, and provide study participants with assigned urine collection device as well as instructions on use. 5. Participants will use a private bathroom to void and collect their urine specimen using either the PEEZY device or standard clean catch method as assigned. 6. Urine specimens will be handed to LOC nursing staff who will separate into 3 aliquots - 1 for clinical lab and 2 for Wolfe lab. 7. Wolfe lab aliquots will be labeled with the subject's study ID and placed at 4°C for \<4 hours before transport to Dr. Wolfe's laboratory for inventory, storage and analysis 8. Clinical lab specimen will be labeled with patient label and transported to clinical lab for standard urine culture per routine obstetric care.

Interventions

DEVICEPeezy urine collection device

use peezy collection to obtain urine sample

Sponsors

Loyola University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Pregnant \< 20 weeks gestational age * Age \> 18 years old * English speaking

Exclusion criteria

* History of recurrent UTIs * Need for ongoing antibiotics * Urinary tract anomalies

Design outcomes

Primary

MeasureTime frameDescription
Urine contamination ratesAugust 2022-August 20231\. To compare the rates of contaminants between CC and PEEZY samples stratified by BMI status (i.e., BMI \< 30 and BMI ≥30)

Secondary

MeasureTime frameDescription
Maternal comorbidities and contaminationAugust 2022-August 2023To compare the rates of contamination based on maternal medical comorbidities

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026